• DOI:10.1517/14622416.5.7.767
• Corpus ID: 5161280

Nucleic acid-based technologies: application amplified.

@article{Kubista2004NucleicAT,
  title={Nucleic acid-based technologies: application amplified.},
  author={Mikael Kubista},
  journal={Pharmacogenomics},
  year={2004},
  volume={5 7},
  pages={
          767-73
        }
}

• M. Kubista
• Published 7 December 2004
• Medicine
• Pharmacogenomics

Au th or P ro In vitro diagnostics is one of the largest markets in the medical technology field, with a revenue of > US$22 billion. Nucleic acid probes tests, estimated at US$1.2 billion in 2002, are forecast to have about five times the growth rate of other products within the diagnostic market over the next 5 years (compound annual growth rate [CAGR] of 21%). Amplified methods are considered to be the primary growth driver and are projected to represent between 75 and 90% of the market in 2006. The technologies, tools, and new applications presented at this year’s meeting supports these optimistic predictions. Also, the rapidly expanding market, leaving space for many players, was reflected by the participants, who were actively seeking partnerships, technological synergies, and complementary methodologies.